Purchase Order HHSO100201600009P
Award Date
4/22/16
Potential Completion Date
12/21/16
Potential Value
$42K
Awardee
Seqirus Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Holly Springs, NC, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a leading global biotechnology company. The contract, valued at $34,163.00, is for the continuation of a physical chemical compatibility study of the H7N9 influenza vaccine with the MF59 adjuvant for an additional 18 months. The contract is a firm fixed-price purchase order with no set-aside...
This federal contract award to Seqirus Inc. was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC). The $402,112 firm fixed-price delivery order is for the acquisition of medical countermeasures (MCMs) for pandemic influenza preparedness and response, including the production, storage, and stability testing of...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a global biotechnology company that develops life-saving medicines and vaccines. The $101,585.00 firm fixed-price delivery order is for storage and stability services related to pandemic preparedness and response, with the work to be performed at Seqirus' facility in Holly Springs, North Carolina....
This federal contract award was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The $4,705.52 firm-fixed-price delivery order is part of a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded to Seqirus in February 2022 to provide a range of medical countermeasures and related services to support pandemic preparedness...
This federal contract award is for $487,277.80 and was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of global biotechnology company CSL Seqirus. The contract is a delivery order under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC), a $13.4 billion vehicle that serves as the primary mechanism for Seqirus' federal contracting activities...
This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The contract, valued at $1,134,584.52, is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC). The contract is for the acquisition of medical countermeasures for pandemic influenza...
This contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The $28,513.00 firm fixed price purchase order is for resampling of HSN 1 monobulk antigen lots manufactured between 2006-2008. This work is performed at Seqirus' facility in Holly Springs, North Carolina. The contract does not have a set-aside designation. Seqirus is a...
This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a leading global biotechnology company. The $3,765,429.00 Delivery Order was placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract, a $13.4 billion IDIQ held by Seqirus with HHS ASPR. The contract is for the Acquisition of Medical Countermeasures...
This contract award to Seqirus Inc., a division of the global biotechnology company CSL Seqirus, was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $20,539,764.00 Delivery Order is for the "Acquisition of MCMS for Pandemic Influenza Preparedness and Response" and is part of a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded to Seqirus in February 2022. Under this IDC, ASPR has...
This federal contract award to Seqirus Inc., a division of global biotechnology company CSL Seqirus, has a ceiling value of $1,904,213.20. The purpose of the contract is to provide medical countermeasures (MCMs), such as vaccines and adjuvants, for pandemic preparedness and response as required by the Department of Health and Human Services (HHS). Seqirus operates a manufacturing facility in Holly Springs, North Carolina and is a leading provider of MCMs to the U.S. federal government. The...